Alsita M50 Tablet ER

Description

Product Description

Alsita M50 Tablet ER is a prescription anti-diabetic medicine formulated with Sitagliptin 50 mg and Metformin Hydrochloride Extended Release (ER). It is commonly prescribed for adults with type 2 diabetes mellitus whose blood glucose levels are not adequately controlled with diet, exercise, or a single anti-diabetic medicine.

Metformin Extended Release helps reduce glucose production in the liver, improves insulin sensitivity, and decreases intestinal glucose absorption. Sitagliptin belongs to the DPP-4 inhibitor class and works by increasing incretin hormone activity, which enhances insulin release after meals and reduces glucagon secretion in a glucose-dependent manner.

When used together with a balanced diet, regular physical activity, and healthy lifestyle modifications, Alsita M50 Tablet ER helps maintain stable blood glucose levels, improve glycemic control, and reduce the risk of diabetes-related complications. It is not intended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Uses

Management of type 2 diabetes mellitus

Helps improve blood glucose control

Supports fasting and post-meal blood sugar management

Used as an adjunct to diet and exercise

Supports long-term diabetes management

Key Benefits

Helps improve overall glycemic control

Controls fasting and postprandial blood glucose levels

Combines two complementary anti-diabetic medicines

Extended-release Metformin provides sustained glucose control

May help reduce HbA1c levels

Low risk of hypoglycemia when used alone

Convenient once-daily extended-release formulation

Manufactured by Alkem Laboratories Ltd.

How to Use

Take Alsita M50 Tablet ER exactly as prescribed by your physician. Swallow the tablet whole with water, preferably with or after meals. Do not crush, chew, or break the extended-release tablet.

How It Works

Metformin Extended Release decreases glucose production in the liver, improves insulin sensitivity, and reduces intestinal glucose absorption. Sitagliptin inhibits the DPP-4 enzyme, increasing incretin hormone levels that stimulate insulin secretion and reduce glucagon release, helping maintain healthy blood sugar levels.

Side Effects

When taken in the prescribed dosage, Alsita M50 Tablet ER is generally well tolerated. However, some individuals may experience:

Diarrhea

Nausea

Vomiting

Abdominal discomfort

Headache

Upper respiratory tract infection

Low blood sugar (especially when used with insulin or sulfonylureas)

Rare allergic reactions

If severe allergic reactions, symptoms of lactic acidosis, severe abdominal pain suggestive of pancreatitis, or unusual symptoms occur, seek immediate medical attention.

Precautions & Warnings

Use only under the supervision of a qualified healthcare professional.

Do not exceed the prescribed dosage.

Do not crush, chew, or break the extended-release tablet.

Not recommended for patients with type 1 diabetes mellitus or diabetic ketoacidosis.

Inform your doctor if you have kidney disease, liver disease, heart failure, or a history of pancreatitis.

Avoid excessive alcohol consumption during treatment.

Monitor blood glucose levels regularly as advised by your physician.

Inform your healthcare provider about all medicines and supplements you are taking to avoid possible drug interactions.

Pregnant and breastfeeding women should consult their doctor before use.

Keep out of reach of children.

Storage Instructions

Store in a cool and dry place.

Protect from moisture and direct sunlight.

Keep the tablets in their original blister pack until use.

Keep out of reach of children.

FAQs

What is Alsita M50 Tablet ER used for?

Alsita M50 Tablet ER is used to improve blood sugar control in adults with type 2 diabetes mellitus along with a healthy diet and regular exercise.

Can Alsita M50 Tablet ER be used for type 1 diabetes?

No. It is intended only for the treatment of type 2 diabetes mellitus and should not be used for type 1 diabetes or diabetic ketoacidosis.

Why should the tablet not be crushed or chewed?

It contains Metformin Extended Release (ER), and crushing or chewing the tablet may interfere with the controlled release of the medicine.

Can Alsita M50 Tablet ER cause low blood sugar?

The risk is generally low when used alone, but it may increase if taken together with insulin or sulfonylureas.

Should I take Alsita M50 Tablet ER with food?

Yes. It is generally recommended to take the tablet with or after meals to improve gastrointestinal tolerability.

Can Alsita M50 Tablet ER be taken with other diabetes medicines?

Yes, it may be prescribed along with other anti-diabetic medicines. Always follow your doctor’s recommendations.

Is Alsita M50 Tablet ER a prescription medicine?

Yes, Alsita M50 Tablet ER is a prescription anti-diabetic medicine containing Sitagliptin and Metformin Hydrochloride Extended Release and should be used only under medical supervision.